Canale-Theakston Carin

Canale-Theakston Carin is listed in filings as Director at Cidara Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 7, 2026, including 10 public disclosures. Recent filings connect the profile to Cidara Therapeutics, Inc. (CDTX). The current snapshot covers public activity from Jul 19, 2024 to Jan 7, 2026. Reported amounts are shown as $365.0K to $87.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.